FDA Grants Approval to Atezolizumab for Alveolar Soft Part Sarcoma

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for […]
Below are links to eighteen publications describing clinical studies of ASPS with novel treatments as well […]
We selected to highlight 3 studies that were presented this year at the ASCO conference: 1.   Treatment […]
An experimental drug, cediranib, may benefit alveolar soft part sarcoma (ASPS) patients, according a recent clinical […]
For Alveolar Soft Part Sarcoms patients the use of aggressive surgery, appropriate diagnostic imaging, and long-term surveillance for […]
Lung metastases affect a significant part of the ASPS patients at some point of their life, […]
Stereotactic Radiosurgery (SRS) is a medical procedure, which is non-invasive surgery to destroy tumors. High dose […]